Calendar Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2025-07-08 EDT			5-day change	1st Jan Change
49.70 ^USD	-0.34%		-1.02%	+28.76%

07-07	Protagonist Therapeutics, Inc. - Special Call
06-17	Citigroup Initiates Protagonist Therapeutics at Buy With $72 Price Target	MT

Chart calendar Protagonist Therapeutics, Inc.

475ef8e87.KLp6xsyaT-evgn0eYWcF-MRPrhvwBunuiZB9EfxXTw4.Qeglv677J7Pk8gtIPhJ2qJMsnkuqbKa6pME8cLNnID147j33o-oJkfjdFg~0a0d2a099f4f66833f213d8189a25479

Upcoming events on Protagonist Therapeutics, Inc.

2025-07-30	Q2 2025 Earnings Release (Projected)
2025-11-04	Q3 2025 Earnings Release (Projected)
2026-03-17	Q4 2025 Earnings Release (Projected)

Past events on Protagonist Therapeutics, Inc.

2025-06-30 16:30	Business Update Call
2025-06-20 13:00	Annual General Meeting
2025-06-04 13:25	Jefferies Healthcare Conference
2025-06-01 15:09	American Society of Clinical Oncology Meeting
2025-03-03 08:30	Phase 3 VERIFY Study of Rusfertide Update Call
2025-02-21 07:00	Q4 2024 Earnings Release
2025-02-06 10:30	Investor Meeting - Key Opinion Leader
2025-01-14 11:15	JP Morgan Healthcare Conference
2024-12-09 21:00	American Society of Hematology Meeting - Publication Number: 4559
2024-12-03 08:45	Evercore ISI HealthCONx Conference - Fireside Chat
2024-11-21 16:30	Business Update Call
2024-11-07 16:05	Q3 2024 Earnings Release
2024-09-10 13:30	H.C. Wainwright Global Investment Conference - Fireside Chat
2024-08-06 14:00	BTIG Virtual Biotechnology Conference
2024-08-06 07:00	Q2 2024 Earnings Release
2024-06-20 13:00	Annual General Meeting
2024-06-14 08:45	European Hematology Association Meeting
2024-06-05 11:00	Jefferies Global Healthcare Conference
2024-05-14 14:45	Capital One Biotech/Biopharma Disruptors Conference - Panel
2024-05-13 14:00	Citizens JMP Life Sciences Conference - Fireside Chat

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	26,6 31,4 -15.46%	60,0 30,0 100%	434 321 35.44%	81,3	179	139
EBITDA Million USD	Released Forecast Spread	0,00 0,00 -	-92,7 -96,0 3.46%	254 179 41.74%	-143	27,0	-33,9
EBIT Million USD	Released Forecast Spread	-131 -125 -5.35%	-93,7 -127 26.5%	253 146 72.72%	-116	-12,9	-70,4
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-127 -127 -0.41%	-79,0 -116 31.76%	279 161 73.23%	-64,0	-15,7	-75,2
Net income Million USD	Released Forecast Spread	-127 -123 -3.53%	-79,0 -115 31.24%	275 170 62.31%	-112	8,67	-75,8
EPS USD	Released Forecast Spread	-2,60 -2,49 -4.44%	-1,39 -2,02 31.28%	4,23 2,52 67.93%	-1,76	-0,42	-1,12
Announcement Date		15/03/23	27/02/24	21/02/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	60,0 30,0 100%	255 120 112.46%	4,17 6,67 -37.5%	4,68 1,81 157.93%	171 56,6 201.23%	28,3 30,4 -6.97%	8,32	8,43	40,7	69,3	6,83	6,85	108
EBITDA Million USD	Released Forecast Spread	-38,1 -43,0 11.44%	23,3 21,0 10.94%	207 -38,0 643.54%	-38,6 -44,0 12.38%	-41,2 -45,0 8.4%	127 116 9.39%	-19,1 -19,0 -0.37%	-40,1	-46,4	-49,3
EBIT Million USD	Released Forecast Spread	-38,3 -42,6 9.96%	23,0 -10,1 328.49%	206 36,9 458.72%	-38,8 -39,8 2.44%	-41,5 -42,2 1.87%	127 10,5 1112.31%	-19,3 -10,8 -78.32%	-40,1	-42,4	-10,8	63,2	-38,1	-39,3	133
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-34,1 -39,7 14.11%	27,3 -8,04 440.04%	211 114 84.39%	-31,3 -42,9 26.99%	-33,6 -36,3 7.29%	134 6,01 2125.63%	-11,7 -30,5 61.83%	-34,0	-35,4	17,0	-24,0	-26,0	-28,0	-7,00
Net income Million USD	Released Forecast Spread	-34,1 -40,2 15.17%	27,3 -7,61 459.24%	207 39,3 427.28%	-30,6 -44,8 31.66%	-33,2 -37,4 11.2%	132 22,5 485.31%	-11,7 -6,14 -89.94%	-36,0	-37,4	-3,60	66,3	-34,5	-35,6	137
EPS USD	Released Forecast Spread	-0,58 -0,69 16.27%	0,44 -0,14 406.9%	3,26 1,19 173.04%	-0,50 -0,73 31.67%	-0,54 -0,61 11.11%	1,98 0,32 516.61%	-0,19 0,00 -8458.56%	-0,58	-0,58	-0,18	0,06	-0,63	-0,65	0,50
Announcement Date		02/11/23	27/02/24	07/05/24	06/08/24	07/11/24	21/02/25	06/05/25	-	-	-	-	-	-	-

Upcoming sector events for Protagonist Therapeutics, Inc.

2025-07-20	MEDPACE HOLDINGS, INC.: Q2 2025 Earnings Release
2025-07-22 07:00	IQVIA HOLDINGS INC.: Q2 2025 Earnings Release
2025-07-22	ALKERMES PLC: Q2 2025 Earnings Release (Projected)
2025-07-22	ICON PUBLIC LIMITED COMPANY: Q2 2025 Earnings Release
2025-07-22	SYNGENE INTERNATIONAL LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-22	EUROFINS SCIENTIFIC SE: Q2 2025 Earnings Release
2025-07-22	LONZA GROUP AG: Q2 2025 Earnings Release
2025-07-23 16:01	GALAPAGOS NV: Q2 2025 Earnings Release
2025-07-24 01:00	BACHEM HOLDING AG: Q2 2025 Earnings Release
2025-07-24	PHARVARIS N.V.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Protagonist Therapeutics, Inc.

2025-06-10 03:20	POLARIS GROUP: May 2025 Sales and Revenue Release
2025-05-29 07:00	IMMUNOVANT, INC.: Q4 2025 Earnings Release
2025-05-22 07:00	REPLIMUNE GROUP, INC.: Q4 2025 Earnings Release
2025-05-21 02:00	BIOARCTIC AB: Q1 2025 Earnings Release
2025-05-20 07:00	CUREVAC N.V.: Q1 2025 Earnings Release
2025-05-14	GI INNOVATION, INC.: Q1 2025 Earnings Release
2025-05-14	GNI GROUP LTD.: Q1 2025 Earnings Release
2025-05-14 16:32	SS INNOVATIONS INTERNATIONAL, INC.: Q1 2025 Earnings Release
2025-05-14 07:30	ARBUTUS BIOPHARMA CORPORATION: Q1 2025 Earnings Release
2025-05-14 07:00	CENTESSA PHARMACEUTICALS PLC: Q1 2025 Earnings Release